CRStar E-News: Quality Measures

Size: px
Start display at page:

Download "CRStar E-News: Quality Measures"

Transcription

1 With the most recent upgrade to CRStar, six quality measures have been added. The user will now see all twelve quality measures in the dashboard reports under the RQRS title. The six new measures have also been added to the reporting module. This e-news will demonstrate how to use each report, as well as list each quality measure by site. SITE QLTY MEASURE CRITERIA Breast BCSRT Radiation therapy is administered w/in 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer (Breast-Rad-Cons) Breast MAC Combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under the age of 70 with AJCC T1cNOM0, or Stage IB-III hormone receptor negative breast cancer. (Breast-Chemo) Breast HT Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with AJCC T1cN0M0, or Stage IB -Stage III hormone receptor positive breast cancer. (Breast-Hormone) Breast nbx Image or palpation-guided needle biopsy (core or FNA) is performed to establish diagnosis of breast cancer. (Breast-Needle Bx) Breast BCS Breast conservation surgery rate for women with AJCC clinical stage 0,I, or II breast cancer. (Breast -Conservation) Breast MASTR Radiation therapy is considered or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with >=4 positive regional lymph nodes(breast-rad/mast) Colon ACT Adjuvant chemotherapy is considered or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer. (Colon Chemo) Colon 12RL At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer. (Colon Lymph Nodes) Rectal RECRT Radiation therapy is considered or administered within 6 months (180 days) of diagnosis for patients under the age of 80 with clinical 1

2 or pathologic AJCC T4N0M0 or Stage III receiving surgical resection for rectal cancer. (Rectal Radiation) Gastric G15TRLN Gastric Measure: At least 15 regional lymph nodes are removed and pathologically examined for resected gastric cancer (Gastric Lymph Nodes) Lung 10RLN Lung measure - At least 10 regional lymph nodes are removed and pathologically examined for AJCC stage IA, IB, IIA, and IIB resected NSCLC. (NSCLC Lymph Nodes) Lung LCT Lung Measure: Systemic chemotherapy is administered within 4 months to day preoperatively or day of surgery to 6 months postoperatively, or it is considered for surgically resected cases with pathologic, lymph nodepositive (pn1) and (pn2) NSCLC. (NSCLC Chemo) 2

3 The new RQRS dashboard report displays the 12 quality measures showing the user the numerator and the denominator. For example, in the first study Breast RAD/CONS 228 patients met the criteria for the quality measure and 176 patients received the recommended treatment. Note: The name of the report will be changing from RQRS to Quality Measures in a future upgrade. The user can change the date range shown by going to Preferences, System Configuration, and then Dashboards as shown below. Enter the date range, click Save, then Exit. Note: Only users with system admin rights have access to the dashboard configurations. 3

4 Another feature has been added to display only the quality measures that the user may want to compare. To remove quality measures from the dashboard report, click directly on the measure to remove as shown below. In this example, all quality measures have been removed except for the breast measures. 4

5 Since adding the new quality measures, the original measures have been moved to a different location in CRStar. They are now located in the reporting module under CPM reports, then Qlty measures. They have been modified so that the user can enter any date range based on diagnosis date. This allows the user to run reports based on a quarter of the year, the entire year or several years at a time. The user should enter the hospital code followed by the date of diagnosis date range of the quality measure to run. Note: only one quality measure can be run at a time. Then click select. In this example, the breast radiation with conservation study was selected. 12 records were selected and indicated in the bottom right corner. This means that 12 patients met the criteria of the quality measure. As the system auto selects the cases that met the criteria for the quality measure, it also auto selects a population of those cases that can later be used in an assortment of ad hoc reports and graphs. See the screenshot below of the auto selected population. 5

6 The user can compare the number of records selected of the quality measure (the denominator) and compare the number to the (numerator) displayed on the dashboard report for the same specified date range. The user can use the auto select population in an ad hoc report to examine criteria for that quality measure as shown below. These comparisons enable the user to work on the numerator to increase the quality of the data more rapidly. 6

Compassionate, team-driven cancer care CLOSE TO HOME.

Compassionate, team-driven cancer care CLOSE TO HOME. Compassionate, team-driven cancer care CLOSE TO HOME. NATIONAL MEASURES FOR ACCOUNTABILITY AND QUALITY IMPROVEMENT The cancer program at OSF HealthCare Sacred Heart Medical Center is accredited by the

More information

Public Reporting of Outcomes 2016

Public Reporting of Outcomes 2016 Public Reporting of Outcomes 2016 The Genesis Cancer Care Institute, Genesis Medical Center, Davenport, Iowa is an American College of Surgeon s Commission on Cancer (CoC) accredited program. The CoC is

More information

Exceptional cancer care, close to home.

Exceptional cancer care, close to home. Exceptional cancer care, close to home. SAINT JOSEPH HOSPITAL ELGIN The AMITA Health Saint Joseph Elgin Medical Center Cancer Program is accredited by the American College of Surgeons (ACoS) Commission

More information

BCS HRH CoC St/% ACT HRH CoC St/% Endometrium CoC St/% ENDCTRT nbx 12RLN ENDLRC Mast RT Rec RT HRH 10 RLN BCS RT G15 RLN LCT MAC OVSAL LNoSurg

BCS HRH CoC St/% ACT HRH CoC St/% Endometrium CoC St/% ENDCTRT nbx 12RLN ENDLRC Mast RT Rec RT HRH 10 RLN BCS RT G15 RLN LCT MAC OVSAL LNoSurg BCS HRH CoC St/% ACT HRH CoC St/% Endometrium CoC St/% 2010 86% n/a 2010 100% 90% ENDCTRT n/a 2011 69% 2011 100% 2010 100% 2012 96% 2012 100% 2013 90% 2013 100% 2012 no data nbx 12RLN 2010 85% 80% 2010

More information

Exceptional cancer care, close to home.

Exceptional cancer care, close to home. Exceptional cancer care, close to home. National Quality Performance Measures Presence Saint Joseph Hospital-Chicago and Presence Saint Francis joined forces in 2015 to become the Presence Lakeshore Region.

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. Annual Report Quality Study Improve process for breast biopsy patients to receive results of pathology reports Background A team from the Baylor Scott & White Medical Center

More information

2015 Public Outcomes Report Cancer Program Practice Profile Reports 2013 Breast and Colon Cancer

2015 Public Outcomes Report Cancer Program Practice Profile Reports 2013 Breast and Colon Cancer As a Commission on Cancer (CoC)-accredited cancer program, HealthEast ensures that patients with cancer are treated according to nationally accepted measures. Measures for Quality of Cancer Care Each year,

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. Annual Report Quality Study Breast Imaging Scheduling Study of Quality Each year, based on the category, the quality improvement coordinator, under the direction of the Cancer

More information

COMMISSION ON CANCER 2013 Cancer Program Practice Profile Reports (CP 3 R)

COMMISSION ON CANCER 2013 Cancer Program Practice Profile Reports (CP 3 R) COMMISSION ON CANCER 2013 Cancer Program Practice Profile Reports (CP 3 R) Women often choose to have a mastectomy with breast reconstruction surgery instead of breast conservation following a breast cancer

More information

COMPREHENSIVE CANCER CENTER/DESERT REGIONAL MEDICAL CENTER 2017 COMMUNITY OUTREACH SUMMARY AND OUTCOMES REPORT

COMPREHENSIVE CANCER CENTER/DESERT REGIONAL MEDICAL CENTER 2017 COMMUNITY OUTREACH SUMMARY AND OUTCOMES REPORT COMPREHENSIVE CANCER CENTER/DESERT REGIONAL MEDICAL CENTER 2017 COMMUNITY OUTREACH SUMMARY AND OUTCOMES REPORT The Health Assessment and Research for Communities (HARC) report, published in January 2017,

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. 1 Annual Report Quality Study Adherence to Adjuvant Systemic Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center McKinney

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. 2016 Annual Report Identification of Disparity of Responsiveness Across Oncology Units at Baylor Scott & White Fort Worth Quality Study Improving Responsiveness of Staff for

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. 216 Annual Report Quality Study Adherence to Adjuvant System Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center Irving

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited

More information

General Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators

General Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without written permission of of the the American College College of Surgeons. of Surgeons.

More information

2018 PUBLIC REPORTING OF OUTCOMES

2018 PUBLIC REPORTING OF OUTCOMES 2018 PUBLIC REPORTING OF OUTCOMES The Cancer Committee at Western Maryland Health System s Schwab Family Cancer Center reports annually on program and patient outcomes in compliance with the accreditation

More information

Bringing the Fight to Cancer Annual Report

Bringing the Fight to Cancer Annual Report Bringing the Fight to Cancer. 21 Annual Report Quality Study Adherence to Adjuvant Systemic Therapy Following Primary Surgery in Stage II Breast Cancer Patients: Baylor Scott & White Medical Center Grapevine

More information

2016 CANCER PROGRAM REPORT. Bay Medical Sacred Heart Health System 615 North Bonita Avenue Panama City, FL

2016 CANCER PROGRAM REPORT. Bay Medical Sacred Heart Health System 615 North Bonita Avenue Panama City, FL 2016 CANCER PROGRAM REPORT Bay Medical Sacred Heart Health System 615 North Bonita Avenue Panama City, FL 32401 850.769.1511 www.baymedical.org 2016 Cancer Program Report Bay Medical Sacred Heart provides

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.

More information

2016 Public Reporting of Outcomes Standard 1.12

2016 Public Reporting of Outcomes Standard 1.12 2016 Public Reporting of Outcomes Standard 1.12 Roland Matthews MD, Director GCCE Sheryl Gabram MD, Deputy Director GCCE Pooja Mishra FACHE, Executive Director GCCE Top 5 Primary Sites 250 200 150 100

More information

Quality Measures: How we develop them and the science behind it

Quality Measures: How we develop them and the science behind it Quality Measures: How we develop them and the science behind it Matthew A Facktor MD FACS Geisinger Medical Center Danville PA Sandra L Wong MD MS FACS FASCO Dartmouth Hitchcock Medical Center Lebanon

More information

Cancer Endorsement Maintenance 2011-Maintenance Measures

Cancer Endorsement Maintenance 2011-Maintenance Measures Measure Number Title Description Measure Steward 0210 Proportion receiving chemotherapy in the last 14 days of life 0211 Proportion with more than one emergency room visit in the last days of life 0212

More information

Partnering for Hope 2015 ANNUAL REPORT

Partnering for Hope 2015 ANNUAL REPORT Partnering for Hope 2015 ANNUAL REPORT PATIENT CARE EVALUATION STUDY DISPARITIES IN THE MANAGEMENT OF ELDERLY BREAST CANCER PATIENTS Cynthia Osborne, MD, Mabel Mardones, MD, Janet Reynolds, CTR, Andrew

More information

Partnering for Hope 2015 ANNUAL REPORT

Partnering for Hope 2015 ANNUAL REPORT Partnering for Hope 2015 ANNUAL REPORT PATIENT CARE EVALUATION STUDY DISPARITIES IN THE MANAGEMENT OF ELDERLY BREAST CANCER PATIENTS Cynthia Osborne, MD, Mabel Mardones, MD, Janet Reynolds, CTR, Andrew

More information

!"#$ Oncology Outcomes Report

!#$ Oncology Outcomes Report !"#$ Oncology Outcomes Report The Cleveland Clinic Florida Cancer Institute is dedicated to the comprehensive care of patients with cancer. Oncologists collaborate with a variety of physicians across multiple

More information

Leveraging Your Cancer Registry: A Strategy for Survey Success

Leveraging Your Cancer Registry: A Strategy for Survey Success CoC-trained consultants on staff Leveraging Your Cancer Registry: A Strategy for Survey Success Toni Hare, RHIT, CTR CoC-trained Consultant Vice President, CHAMPS Oncology November 27, 2012 Georgia s Best

More information

MemorialCare Breast Center at Long Beach Memorial

MemorialCare Breast Center at Long Beach Memorial MemorialCare Breast Center at Long Beach Memorial (562) 933-7880 MemorialCare.org/LBBreast Todd Cancer Pavilion, 2 nd Floor 2810 Long Beach Blvd. Long Beach, CA 90806 The Breast Center at the MemorialCare

More information

Exceptional cancer care, close to home.

Exceptional cancer care, close to home. Exceptional care, close home. 2017 Annual Reptg Outcomes 1 Permance Measures Surgery not first treatment certa lung s Measure: Surgery not first treatment course cn2, M0 lung cases outcomes: permance rate

More information

St. Vincent s Riverside Cancer Program Cancer Report

St. Vincent s Riverside Cancer Program Cancer Report St. Vincent s Riverside Cancer Program 2018 Cancer Report 1 Table of Contents St. Vincent s Riverside Cancer Program... 1 Cancer Registry... 4 St. Vincent s Riverside Cancer Program practice profile report...

More information

MemorialCare Breast Center at Long Beach Medical Center

MemorialCare Breast Center at Long Beach Medical Center MemorialCare Breast Center at Long Beach Medical Center 2017 ANNUAL REPORT 562.933.7880 memorialcare.org/lbbreast Todd Cancer Pavillion, 2 nd Floor 2810 Long Beach Blvd. Long Beach, CA 90806 The MemorialCare

More information

Data and Metrics for Evaluating and Improving Cancer Care Quality in Georgia

Data and Metrics for Evaluating and Improving Cancer Care Quality in Georgia Data and Metrics for Evaluating and Improving Cancer Care Quality in Georgia Updates for GATRA on: 1) Augmenting GA Cancer Registry Data to Assess Adherence of Quality-of-Care Metrics 2) Commission on

More information

Cancer Services 2018 Quality Report

Cancer Services 2018 Quality Report Cancer Services 2018 Quality Report MAURY REGIONAL CANCER CENTER Clinical Excellence The Maury Regional Cancer Center is a comprehensive treatment center committed to medical excellence. We combine stringent

More information

WASHINGTON. Spokane Cheney. Olympia. Tri-Cities. Walla Walla. Portland North Central Oregon City OREGON. Mt. Vernon. Port Angeles

WASHINGTON. Spokane Cheney. Olympia. Tri-Cities. Walla Walla. Portland North Central Oregon City OREGON. Mt. Vernon. Port Angeles 2 3 Mt. Vernon Port Angeles Bremerton Tacoma 5 5 Olympia Everett Edmonds Seattle 90 WASHINGTON 90 Spokane Cheney Pullman Longview 82 Tri-Cities Portland North Central Oregon City 5 84 OREGON Walla Walla

More information

Making the Most of Your Cancer Registry

Making the Most of Your Cancer Registry www.champsods.com Making the Most of Your Cancer Registry Presenter: Toni Hare, Vice President CHAMPS Oncology Data Services Picture of girl here December 11, 2009 Learning Objectives Upon completion of

More information

Defining Safety and Quality Across the Cancer Care Continuum

Defining Safety and Quality Across the Cancer Care Continuum Defining Safety and Quality Across the Cancer Care Continuum Defining Safety and Quality Across the Cancer Care Continuum April 28, 2016 Kristen Fessele, PhD, RN University of Utah Funding NINR T32NR013456

More information

2018 Quality and Outcomes Report

2018 Quality and Outcomes Report 18 Quality and Outcomes Report TABLE OF CONTENTS Quality Review Quality Accreditations Quality Comparison Measures Quality Improvements 18 Community Outreach Activities and Outcomes Clinical Education

More information

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process Wednesday, April 29, 2009 at 11 AM Central M. Asa Carter, CTR Manager, Approvals and Standards

More information

Shore Medical Center Site-Specific Study: Colorectal Cancer 2013

Shore Medical Center Site-Specific Study: Colorectal Cancer 2013 Shore Medical Center Site-Specific Study: Colorectal Cancer Shore Medical Center Site-Specific Study: Colorectal Cancer The following report is the result of a collaborative effort of four physician members

More information

Cancer Program Report 2014

Cancer Program Report 2014 Cancer Program Report 2014 Queen of the Valley Hospital St Joseph Health Queen of the Valley Hospital - 2014 Site Table Site Total Class Sex Group Cases Analytic NonAn M F 0 I II ALL SITES 661 494 167

More information

Cancer Annual Report. Our story begins with you.

Cancer Annual Report. Our story begins with you. Cancer Annual Report 17 Our story begins with you. Chairman s message The Cancer Committee is formed under the direction of the Bylaws of the Medical Executive Committee and serves to monitor, supervise

More information

2016 Annual Report BON SECOURS CANCER INSTITUTE Bon Secours Maryview Medical Center

2016 Annual Report BON SECOURS CANCER INSTITUTE Bon Secours Maryview Medical Center 2016 Annual Report BON SECOURS CANCER INSTITUTE Bon Secours Maryview Medical Center Mission: The mission of the Bon Secours Health System is to bring compassion to health care and to be Good Help to Those

More information

NATIONAL QUALITY FORUM

NATIONAL QUALITY FORUM Cancer Endorsement Maintenance Table of Submitted Measures Phase I 0210 1 Proportion receiving chemotherapy in the last 14 days of life Percentage of patients who died from cancer receiving chemotherapy

More information

Outcomes Q&A NAACCR Webinar Series July 7, 2016

Outcomes Q&A NAACCR Webinar Series July 7, 2016 Outcomes 2015-2016 NAACCR Webinar Series July 7, 2016 1 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar at your

More information

Cancer Center Dashboard

Cancer Center Dashboard Cancer Center Dashboard Measure Definition Benchmark Endorsed By Screening Breast Cancer Screening Percentage of eligible women 40-69 who received a mammogram within the past 24 months NCQA reported average:

More information

RQRS: From Idea to Reality

RQRS: From Idea to Reality RQRS: From Idea to Reality Andrew K. Stewart GATRA November 9, 2011 Ensuring Quality of Care Institute of Medicine Report of 1999 Noted that the quality of cancer care varies in the United States. Recommended

More information

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions. Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to

More information

RECTAL MEASURE SPECIFICATIONS

RECTAL MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) RECTAL MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve

More information

2014 Oncology Measures Group Overview

2014 Oncology Measures Group Overview 2014 Oncology Measures Group Overview The Oncology Measures Group is a reporting option that significantly reduces the burden of participation in the Physician Quality Reporting System (PQRS). Source:

More information

Oncology Report to the Community. Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital

Oncology Report to the Community. Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital Oncology Report to the Community Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital 1 Contents Letter from Leadership.... 1 Survivorship: Life After Cancer Treatment....

More information

A Year in Review. September 30 and October 1, 2017 were the dates for the expanded

A Year in Review. September 30 and October 1, 2017 were the dates for the expanded December 29, 2017 Annual Report By any standard 2017 was an eventful year for the Cancer Centers of Southwest Oklahoma (CCSO). There were new clinical programs, the renewal of an important accreditation,

More information

In 2015, The Methodist

In 2015, The Methodist 2016 Annual Report METHODIST JENNIE EDMUNDSON CANCER CENTER Annual Report Jennie continues to reach further into our communities in an effort to enhance both the quality and accessibility of cancer care,

More information

Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)

Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) MEASURE SPECIFICATIOS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) ational Cancer Data Base (CDB) staff has undertaken

More information

Centegra Cancer Program Annual Review 2017

Centegra Cancer Program Annual Review 2017 Centegra Cancer Program Annual Review 2017 Summarizing data from the year 2016 Welcome Dear Community and Health Care Team Members, As the leading provider of comprehensive care in McHenry County, Centegra

More information

Please submit all questions concerning webinar content through the Q&A panel. Reminder:

Please submit all questions concerning webinar content through the Q&A panel. Reminder: NAACCR 2015-2016 Clinical Outcomes and Webinar Quality Series Improvement: Oncology Dashboard Drivers NAACCR Webinar Series 2016 2017 Lisa D. Landvogt, BA, CTR LLandvo1@hfhs.org Jocelyn Hoopes, MLIS, CTR,

More information

Tools, Reports, and Resources

Tools, Reports, and Resources Tools, Reports, and Resources What the National Cancer Database (NCDB) does for CoC-Accredited Programs By using the NCDB, CoC-accredited programs can proactively improve delivery and quality of care for

More information

Financial Disclosure. Learning Objectives. Review and Impact of the NCDB PUF. Moderator: Sandra Wong, MD, MS, FACS, FASCO

Financial Disclosure. Learning Objectives. Review and Impact of the NCDB PUF. Moderator: Sandra Wong, MD, MS, FACS, FASCO Review and Impact of the NCDB PUF Moderator: Sandra Wong, MD, MS, FACS, FASCO Financial Disclosure I do not have personal financial relationships with any commercial interests Learning Objectives At the

More information

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised. Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of

More information

Colorectal Cancer at the MemorialCare Todd Cancer Institute at Long Beach Memorial

Colorectal Cancer at the MemorialCare Todd Cancer Institute at Long Beach Memorial Colorectal Cancer at the MemorialCare Todd Cancer Institute at Long Beach Memorial ANNUAL REPOR T (562) 933-0900 MemorialCare.org/TCI 2810 Long Beach Blvd. Long Beach, CA 90806 #3 Colorectal cancer is

More information

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer.

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer. Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer. Goal of the study: 1.To assess whether patients at Truman

More information

Loco-Regional Management After Neoadjuvant Chemotherapy

Loco-Regional Management After Neoadjuvant Chemotherapy 1 Loco-Regional Management After Neoadjuvant Chemotherapy Terry Mamounas, M.D., M.P.H., F.A.C.S. Medical Director, Comprehensive Breast Program UF Health Cancer Center at Orlando Health Professor of Surgery,

More information

Annual Report CANCER REGISTRY. at Eastern Regional Medical Center. Cancer Treatment Centers of America. Philadelphia, Pennsylvania.

Annual Report CANCER REGISTRY. at Eastern Regional Medical Center. Cancer Treatment Centers of America. Philadelphia, Pennsylvania. CANCER REGISTRY Annual Report 207 Cancer Treatment Centers of America at Eastern Regional Medical Center Philadelphia, Pennsylvania Chicago, Illinois Atlanta, Georgia Tulsa, Oklahoma Phoenix, Arizona 206

More information

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:

More information

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised. Case Scenario 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of alcohol.

More information

Evaluation of the Axilla Post Z-0011 Trial New Paradigm

Evaluation of the Axilla Post Z-0011 Trial New Paradigm Evaluation of the Axilla Post Z-0011 Trial New Paradigm Belinda Curpen, MD, FRCPC; Tetyana Dushenkovska; Mia Skarpathiotakis MD, FRCPC; Carrie Betel, MD, FRCPC; Kalesha Hack, MD, FRCPC; Lara Richmond,

More information

Celebrating 10 years of Community Cancer Treatment at Tebo Family Medical Pavilion

Celebrating 10 years of Community Cancer Treatment at Tebo Family Medical Pavilion 2017 CANCER REPORT TO THE COMMUNITY Celebrating 10 years of Community Cancer Treatment at Tebo Family Medical Pavilion IN PARTNERSHIP WITH A Letter to the Community Boulder Community Health takes pride

More information

Department of Endocrine & Breast Surgery Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

Department of Endocrine & Breast Surgery Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India Department of Endocrine & Breast Surgery Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India Evidence-Based Pragmatic SGPGI Breast Cancer Management Protocols (Summary) Background:

More information

Loco-Regional Management After Neoadjuvant Chemotherapy

Loco-Regional Management After Neoadjuvant Chemotherapy 1 Loco-Regional Management After Neoadjuvant Chemotherapy Terry Mamounas, M.D., M.P.H., F.A.C.S. Medical Director, Comprehensive Breast Program UF Health Cancer Center at Orlando Health Professor of Surgery,

More information

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 Landmark Medical Center offers a comprehensive cancer care services to our patients. LMC Cancer program is committed to ensure that patients receive

More information

Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)

Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) O COLON MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff

More information

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

NPQR Quality Payment Program (QPP) Measures 21_18247_LS. NPQR Quality Payment Program (QPP) Measures 21_18247_LS MEASURE ID: QPP 99 MEASURE TITLE: Breast Cancer Resection Pathology Reporting pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes)

More information

QUALIFIED CLINICAL DATA REGISTRY (QCDR) 2017 MEASURE SPECIFICATIONS

QUALIFIED CLINICAL DATA REGISTRY (QCDR) 2017 MEASURE SPECIFICATIONS QOPI5 Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Percentage of adult patients with metastatic solid tumors

More information

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment? Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen

More information

NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions

NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without

More information

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases

More information

Breast Cancer. Saima Saeed MD

Breast Cancer. Saima Saeed MD Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast

More information

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Layman s terms: cancer starts when cells grow out of control (in any place in the body) and crowd out normal cells

More information

2017 Quality and Outcomes Report

2017 Quality and Outcomes Report 217 Quality and Outcomes Report TABLE OF CONTENTS Quality Review page 2 Quality Accreditations page 2 Quality Measures page 4 Quality Improvements page 6 Community Outreach Activities and Outcomes page

More information

CENTEGRA CANCER PROGRAM ANNUAL REVIEW 2018 SUMMARIZING DATA FROM THE YEAR 2017

CENTEGRA CANCER PROGRAM ANNUAL REVIEW 2018 SUMMARIZING DATA FROM THE YEAR 2017 CENTEGRA CANCER PROGRAM ANNUAL REVIEW 2018 SUMMARIZING DATA FROM THE YEAR 2017 A YEAR IN REVIEW 2017 Jerry Liu, MD Medical Oncology Cancer Liaison Physician FROM DR. JERRY X, LIU Centegra Hospital McHenry

More information

PROMEDICA MONROE REGIONAL HOSPITAL Annual Report

PROMEDICA MONROE REGIONAL HOSPITAL Annual Report PROMEDICA MONROE REGIONAL HOSPITAL 2015 Annual Report Includes Data Collected Through 2014 Welcome from the Cancer Committee Leadership With great pleasure, we present the 2015 ProMedica Monroe Regional

More information

2016 Public Outcomes Report

2016 Public Outcomes Report 2016 Public Outcomes Report The Lefcourt Family Cancer Treatment and Wellness Center at Englewood Hospital and Medical Center is a Compre hensive Community Cancer Program, designated by the Commission

More information

DOES NEOADJUVANT Rx REALLY DOWN STAGE BR CA? DR KHANYILE DEPARTMENT OF MEDICAL ONCOLOGY, University of Pretoria

DOES NEOADJUVANT Rx REALLY DOWN STAGE BR CA? DR KHANYILE DEPARTMENT OF MEDICAL ONCOLOGY, University of Pretoria DOES NEOADJUVANT Rx REALLY DOWN STAGE BR CA? DR KHANYILE DEPARTMENT OF MEDICAL ONCOLOGY, University of Pretoria BREAST CA STAGING TNM STAGING: - T x N - x - 0-0 - is - 1-1(1mic/1a/1b/1c) - 2(a/b) - 2-3(a/b/c)

More information

Breast Cancer Treatment

Breast Cancer Treatment Breast Cancer Treatment Treatment 2 aspects 1. Treatment of the breast itself: Local Treatment 2. Treatment of the whole body = Systemic treatment Local Treatment Surgery +/- Radiation Usually: a. Breast

More information

Lecture 5. Primary systemic therapy: clinical and biological endpoints

Lecture 5. Primary systemic therapy: clinical and biological endpoints Lecture 5 Primary systemic therapy: clinical and biological endpoints Valentina Guarneri, M.D., Ph.D. Primary systemic therapy in breast cancer Firstly introduced d into clinical i l practice in 70s for

More information

10. HPV-Mediated (p16+) Oropharyngeal Cancer

10. HPV-Mediated (p16+) Oropharyngeal Cancer 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

Early-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion

Early-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion Early-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion Pieter Postmus The Clatterbridge Cancer Centre Liverpool Heart and Chest Hospital Liverpool, United Kingdom 1 2

More information

2016 Cancer Registry Annual Report

2016 Cancer Registry Annual Report 2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,

More information

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior

More information

W3C Life Sciences: Clinical Observations Interoperability: EMR + Clinical Trials Use-case for EMR + Clinical Trials Interoperability

W3C Life Sciences: Clinical Observations Interoperability: EMR + Clinical Trials Use-case for EMR + Clinical Trials Interoperability W3C Life Sciences: Clinical Observations Interoperability: EMR + Clinical Trials Use-case for EMR + Clinical Trials Interoperability Background: The key issue is to investigate whether some of the data

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.

More information

Requirements for Abstracted Text

Requirements for Abstracted Text Slide 1 Requirements for Abstracted Text Principles of Abstracting Lesson 3: Purpose of Text Slide 2 Available Text Fields Place of Diagnosis Immunotherapy Chemotherapy Hormone Therapy Other Therapy Radiation

More information

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

制定阮綜合醫療社團法人阮綜合醫院乳癌 (Breast Cancer) 治療共識

制定阮綜合醫療社團法人阮綜合醫院乳癌 (Breast Cancer) 治療共識 2006.03.09 制定阮綜合醫療社團法人阮綜合醫院乳癌 (Breast Cancer) 治療共識 2007.10.01 修訂 2009.04.22 修訂 2010.04.07 審閱 LCIS (Lobular Carcinoma in Situ) 2011.12.07 修訂 2012.03.07 修訂 Diagnosis Workup Risk Reduction Surveillance Biopsy

More information

Treatment of Locally Advanced Rectal Cancer: Current Concepts

Treatment of Locally Advanced Rectal Cancer: Current Concepts Treatment of Locally Advanced Rectal Cancer: Current Concepts James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation

More information

2016 Annual Report BON SECOURS CANCER INSTITUTE Bon Secours DePaul Medical Center

2016 Annual Report BON SECOURS CANCER INSTITUTE Bon Secours DePaul Medical Center 2016 Annual Report BON SECOURS CANCER INSTITUTE Bon Secours DePaul Medical Center Mission: The mission of the Bon Secours Health System is to bring compassion to health care and to be Good Help to Those

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #450 (NQF 1858): Trastuzumab Received By Patients With AJCC Stage I (T1c) III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy National Quality Strategy Domain: Effective Clinical

More information

General Information Key Points

General Information Key Points The content of this booklet was adapted from content originally published by the National Cancer Institute. Male Breast Cancer Treatment (PDQ ) Patient Version. Updated September 29,2017. https://www.cancer.gov/types/breast/patient/male-breast-treatment-pdq

More information

2013 ANNUAL CANCER REPORT

2013 ANNUAL CANCER REPORT 213 ANNUAL CANCER REPORT CONTENTS EXECUTIVE SUMMARY 1 CANCER PROGRAM OUTCOMES Cancer Volume for the System 1 Cancer Volume by Hospital Location 2 COMMISSION ON CANCER ACCREDITATION AND THE NATIONAL CANCER

More information

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed

More information

Anaplastic A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.

Anaplastic A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells. Oncology Terminology A Adenocarcinoma A cancerous tumor that arises in or resembles glandular tissue. Adjunct agent In cancer therapy, a drug or substance used in addition to the primary therapy. Adjuvant

More information

Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours?

Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours? Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours? Question #2: How are cardia tumours managed? Michael F. Humer December 3, 2005 Vancouver, BC Case

More information